59 results
DEFA14A
VERV
Verve Therapeutics Inc
29 Apr 22
Additional proxy soliciting materials
7:22am
that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all … to
www.proxydocs.com/VERV
Have the 12 digit control number located in the shaded box above available
when you access the website and follow the instructions
DEFA14A
VERV
Verve Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
7:56am
. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained … number located in the box above available when you access the website and follow the instructions. Copyright © 2024 BetaNXT, Inc. or its affiliates
DEFA14A
VERV
Verve Therapeutics Inc
28 Apr 23
Additional proxy soliciting materials
7:49am
to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important … digit control number located in the shaded box above available when you access the website and follow the instructions. If you want to receive a paper
S-1
EX-10.13
VERV
Verve Therapeutics Inc
28 May 21
IPO registration
4:04pm
) and, to the extent agreed by Sublandlord, the right to access back-up emergency power) by paying to Sublandlord Subtenant’s Percentage for Building shared utilities … of the Prime Lease and Prime Lessor’s exercise of any rights it may have thereunder to restrict access to the Building, Subtenant shall have access
DRS
EX-10.14
VERV
Verve Therapeutics Inc
16 Apr 21
Draft registration statement
12:00am
) and, to the extent agreed by Sublandlord, the right to access back-up emergency power) by paying to Sublandlord Subtenant’s Percentage for Building shared utilities … of the Prime Lease and Prime Lessor’s exercise of any rights it may have thereunder to restrict access to the Building, Subtenant shall have access
S-1
EX-10.1
9sa4y9keygv kd
28 May 21
IPO registration
4:04pm
DRS
EX-10.1
eks6n783fo9ce
16 Apr 21
Draft registration statement
12:00am
10-K
1xp43m 3yqs
14 Mar 22
Annual report
7:04am
S-1/A
n986x 4pex
14 Jun 21
IPO registration (amended)
6:15am
DRS
zpyrph2
16 Apr 21
Draft registration statement
12:00am
424B4
w8lh9ujp 9vz
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1
lzxbi 78w
28 May 21
IPO registration
4:04pm
10-Q
yi7hvrg cpij
12 Aug 21
Quarterly report
8:53am